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Abstract 
Patients with esophageal symptoms potentially associated to esophageal motor disorders such as 
dysphagia, chest pain, heartburn and regurgitation, represent one of the most frequent reasons for 
referral to gastroenterological evaluation. The utility of esophageal manometry in clinical practice 
is: (1) to accurately define esophageal motor function, (2) to identify abnormal motor function, and 
(3) to establish a treatment plan based on motor abnormalities. With this in mind,  in the last 
decade, investigations and technical advances, with the introduction of high-resolution esophageal 
manometry, have enhanced our understanding and management of esophageal motility disorders. 
The following recommendations were developed to assist physicians in the appropriate use of 
esophageal manometry in modern patient care. They were discussed and approved after a 
comprehensive review of the medical literature pertaining to manometric techniques and their 
recent application. This position statement created under the auspices of the Gruppo Italiano di 
Studio per la Motilità dell'Apparato Digerente (GISMAD), Società Italiana di Gastroenterologia ed 
Endoscopia Digestiva (SIGE) and Associazione Italiana Gastroenterologi Ospedalieri (AIGO) is 
intended to help clinicians in applying manometric studies in the most fruitful manner within the 
context of their patients with esophageal symptoms. 
 
Esophageal Physiology 
 The pharynx and esophagus act synergistically to transport food, saliva and secretions from 
the mouth into the stomach.   
 The esophagus starts at the cricoid cartilage and ends at the diaphragmatic level, with a 
length of 20-25 cm. The upper esophageal sphincter (UES) is the proximal border of the esophagus 
and acts as a valve [1, 2]. Indeed, its main functions are avoiding air entering into the esophagus 
during breathing and preventing refluxing of food and saliva from the esophagus to the airways. It 
is innervated by the glossopharyngeal nerve, and branches of the vagus and sympathetic nerves and 
is located behind the cricoid cartilage. It is made up mainly of cricopharyngeus and 
thyropharyngeus muscles and is manometrically identifiable as a 3-4 cm high pressure zone. UES 
pressure, mainly oriented toward the anterior-posterior direction, decreases during sleep and 
anesthesia and with ageing, whereas it increases during inspiration and phonation, psychological 
stress and anxiety. A swallow-induced UES relaxation takes 0.3-0.5 s, depending on the bolus 
volume [1]. The esophageal wall is made up of mucosa, submucosa and muscularis propria. The 
presence of skeletal muscle characterizes the upper portion, whereas the presence of smooth muscle 
is typical of the lower part, with a mixture of striated and smooth muscle in the middle portion 
(“transition zone”). Topographically, the esophagus can be divided into: a) Cervical: from UES to 
the suprasternal notch (4-5 cm long); b) Thoracic: from suprasternal notch to the diaphragmatic 
hiatus; c) Abdominal: from diaphragmatic hiatus to the cardia of the stomach (1 cm long). The 
lower esophageal sphincter (LES) is the distal border of the esophagus: it is made up of a thickened 
longitudinal and a circular muscle layer; the thickness increases or decreases with increase or 
decrease in LES pressure [3]. Clasp and sling fibers characterize the LES muscles: the former, 
mainly innervated by inhibitory neurons, maintain myogenic tone, whereas the sling fibers, mainly 
innervated by excitatory neurons, respond quickly to cholinergic agonists [1, 4]. The LES passes 
from the chest into the abdomen through the crural diaphragm (CD), thus allowing continuity with 
the stomach. The CD, innervated by phrenic nerves, is made up of medial fibers located in a 
circumferential way and lateral fibers oriented in an oblique direction and it is strongly anchored to 
the LES by the phreno-esophageal ligament [5]. The intrinsic nervous system is made up of the 
myenteric plexus, with excitatory neurons containing acetylcholine (Ach) and substance P and 
inhibitory neurons containing nitric oxide (NO) synthase and vasointestinal active peptide (VIP), 
and Meissner’s plexus. Interstitial cells of Cajal (ICCs) are also present and play a major role in 
neuromuscular transmission [1]. Extrinsic esophageal innervation is provided by both 
parasympathetic and sympathetic nerves. The vagus nerve, whose cell bodies are located in the 
dorsal motor nucleus (DMN) of the vagus and nucleus ambiguous in the brain stem, is the main 
motor nerve of the esophagus (muscles and secreto-motor innervation of the glands). Smooth 
muscle is provided by two different type of fibers originating from different types of DMN neurons: 
short latency fibers synapsing with myenteric inhibitory neurons and long latency fibers synapsing 
with myenteric cholinergic excitatory neurons. It also carries mechano-sensory (chemical, 
mechanical, thermal) information from the esophageal wall [6]. The sympathetic nerve supply 
comes from the intermedio-lateral cell columns of the T1-T10 spine and modulates contraction of 
blood vessels, esophageal sphincter tone, relaxation of the muscular wall and also glandular 
functions.  
 Swallow events are regulated and coordinated by the swallow pattern generators (SPG), 
neuronal networks localized in the brain stem (nucleus tractus solitaries, nucleus ambiguous and 
DMN of the vagus) which are also involved in controlling respiration and in cardiovascular 
reflexes. SPG are voluntarily activated (primary peristalsis), but they can also be involuntarily 
elicited in a reflex way (e.g. in secondary peristalsis) [7]. After food is mixed with saliva and 
reduced to a bolus, the contraction of the tongue against the palate pushes it toward the pharynx 
(oral phase), then the elevation of the soft palate closes the nasopharynx, preventing nasal 
regurgitation, and the contraction of the suprahyoid muscle closes the laryngeal inlet, providing a 
further protective mechanism for the airways. In the meantime, the UES relaxes and pharyngeal 
peristalsis takes about one second to push the bolus toward the esophagus (pharyngeal phase) [1]. 
Esophageal peristalsis is regulated via the parasympathetic pathway by the vagus nerve and the 
intrinsic enteric nervous system. In particular, the UES and proximal striated esophageal muscle 
activity is modulated by a sequential excitation of lower motor neurons of the nucleus ambiguous, 
whereas peristalsis of smooth muscle is controlled by central and peripheral mechanisms. The 
central mechanisms imply the coordinated activity of both short- and long-latency vagal fibers. 
Indeed, swallow firstly activates the short latency nitrergic inhibitory fibers, which inhibit the 
esophagus motor activity. Subsequently, there is an activation of cholinergic excitatory neurons [8]. 
This mechanism prevents another peristaltic wave taking place if a second swallow starts within 10 
seconds, enabling a coordinated and efficient motor activity [9, 10]. The direction, the amplitude 
and the speed of propagation are regulated by regional differences in the density of the inhibitory 
and excitatory neurons of the myenteric plexus. Indeed, inhibitory activity increases in the distal 
portion of the esophagus, thus delaying the onset of contraction and allowing propagation to move 
in a cranio-caudal direction [11-13]. Deglutitive inhibition is clearly shown by the “multiple rapid 
swallowing” test performed during manometry: esophageal body and LES remain relaxed and only 
after the last swallow can a peristaltic wave start [14]. Peristalsis is characterized by the coordinated 
contraction (behind the bolus) and relaxation (in front of the bolus) of the circular and longitudinal 
muscle layers: longitudinal muscle contraction foregoes the circular muscle contraction and lasts 
more than the circular contraction by 2-4 seconds. The contraction of circular muscle in a sequential 
manner causes bolus progression (primary peristalsis) whereas the contraction and the relaxation of 
longitudinal muscle provokes shortening and lengthening of the esophagus, respectively [15]. A 
normal peristaltic wave lasts from 6 to 10 seconds; wet swallows induce higher amplitude 
contractions with a lower speed of peristalsis than the dry ones, whereas a warm bolus increases and 
a cold one decreases the amplitude of contractions. Secondary peristalsis has been observed in the 
presence of a retained bolus in the esophagus or in case of distension. The latter is possibly 
associated with gastroesophageal reflux, which induces a local reflex independent of the vagal input 
from the DMN: in these cases contraction waves begin immediately above the bolus (or the reflux 
content) and proceed toward the distal esophagus without any involvement of the proximal portion 
of the viscous [16].  
The esophagogastric junction (EGJ) is an antireflux barrier allowing the passage of esophageal 
contents into the stomach and is made up of the LES and crural diaphragm. The LES is controlled 
by autonomic nerves and the myenteric plexus and has its own myogenic tone regulated by 
hormonal, paracrine and neural factors. As a consequence, LES pressure is modulated by many 
hormones and paracrine substances (VIP, CCK, CGRP, dopamine, GIP, galanin, gastrin, serotonin, 
sexual hormones, substance P, glucagon, NO, etc.) [1, 7]. The crural diaphragm is a ventilator 
muscle, which has also a “sphincter–like” action. Indeed, separation of the LES from the crural 
diaphragm, as observed in hiatus hernia, can reduce the efficacy of antireflux barrier. Moreover, 
EGJ pressure increase during inspiration is due to crural diaphragm contraction and is related to the 
depth of inspiration. Abdominal compression, straight leg raise or Valsalva maneuver induce crural 
diaphragm contraction, which provides the necessary increase of EGJ pressure to avoid 
gastroesophageal reflux. The same happens with inspiration, during which there is an increase in 
negative intra-esophageal pressure and in gastric positive pressure [1, 5]. Normal resting LES 
pressure ranges from 10 to 30 mm Hg. Physiological LES relaxation starts immediately after the 
onset of swallow, lasting about 6 seconds, which is the time that a peristaltic wave takes to pass 
through the esophagus. After the peristaltic wave ends, the LES closes with a “rebound” pressure 
increase (pressure levels higher than basal levels) lasting 5-10 seconds [1]. During breathing and 
swallow-induced relaxation, the LES and crural diaphragm move together, but they can separate 
from each other during peristalsis and transient lower esophageal sphincter relaxation (TLESR) [1], 
which is a spontaneous relaxation of the esophagus. It was first observed in GERD and 
subsequently described also during belching, regurgitation, rumination and vomiting, even if it can 
also occur in normal subjects in coincidence with a “physiological reflux”. TLESR is a vagal reflex 
elicited by gastric distension and/or pharyngeal stimulation, but not by swallowing. It is 
accompanied by relaxation of the crural diaphragm together with an inhibition of the body of the 
esophagus. It generally lasts more than a normal swallow induced relaxation (>10 seconds) [5, 7, 
17]. 
  
Manometric Assemblies, Standard Procedure, Adjunctive 
Tests and Classifications of Esophageal Motility Disorders 
The esophageal motor function can be assessed by a variety of recording techniques 
including radiology, scintigraphy, manometry, and most recently intraluminal electrical impedance 
monitoring. Esophageal manometry is considered the “gold-standard” for the assessment of motor 
disorders and may be summarized in 3 domains: a) to accurately define esophageal motor function, 
b) to define abnormal motor function, and c) to delineate a treatment plan based on motor 
abnormalities.  
 
MANOMETRIC ASSEMBLIES 
Water perfused system. Water-perfused esophageal manometry catheters typically are configured 
with 3-8 pressure-sensing side-holes, which usually are spaced at 5 cm intervals on catheters with 3-
4 sensors. The recorded pressure rises when the flow of water through the side-hole of a tube is 
impeded by circumferential contraction of the wall of the esophagus. A low- compliance pneumo-
hydraulic pump is used to slowly perfuse the tubes with bubble-free water [18]. Upper and lower 
esophageal sphincters are detected with a manual pull-through technique unless a sleeve device is 
used (generally for the lower esophageal sphincter) enabling to keep the catheter in the same 
position for assessment of both esophageal body and sphincter motility [19]. The major 
disadvantage of the above systems is that the equipment is precarious and requires continuing 
maintenance. Further, it may be difficult to reliably record the motor function of the esophageal 
sphincters with manometric catheters using water-perfused side-holes as sensor-like points a few 
cm apart. By increasing the number of channels and having closely spaced side holes it is possible 
to perform water perfused high resolution manometry [20]. 
High-resolution solid-state manometry. An alternative to perfused manometric systems is 
an assembly incorporating miniature strain gauge sensors and solid-state electronic components. 
The micro-transducers directly interface with the recorder, and the resultant system has a vastly 
expanded frequency response suitable for pharyngeal recording. Solid state is now considered as 
cheap as perfused systems, requires less maintenance and is generally used for esophageal high-
resolution manometry (HRM) [21], although in emerging economies and in the Asian Pacific 
Region the majority of systems are still water perfused. This technique is characterized by an 
increased number of pressure sensors (up to 36 sensors) spaced closely. HRM has some advantages 
in clinical practice: in contrast to conventional manometry the pull-through for detecting sphincters 
is not required and shifts of position do not affect the reliability and reproducibility of pressure 
recordings. Moreover, in order to better visualize the data, it has been incorporated a process of 
interpolation between sensors to display the information in the form of seamless isobaric color 
regions on esophageal pressure topography plots (EPT) [21], which represent esophageal motility 
and sphincter functions on color-coded, pressure-space-time plots. The main disadvantage is that 
the equipment cannot be introduced and moved using an endoscopic-positioned wire in patients 
with diverticula or difficult EGJ (i.e. large hiatal hernia or spasm).  
Impedance manometry. The combined measurement of impedance and pressure in the esophagus 
evaluates esophageal motility and bolus transport patterns. Impedance adds some aspects of bolus 
transport as clearing velocity, correlation between LES relaxation and bolus transit, esophageal 
bolus retention (when hypokinetic peristaltic defects are present). Using combined impedance–
manometry additional data about esophageal motor function and associated bolus transport can be 
obtained during a single investigation without the use of radiation [22] Savarino et al showed a 
correlation between esophageal motor abnormalities and bolus transit defects in different 
subcategory of GERD patients [23]. Moreover, Pohl D et al proposed a bolus velocity cut-off in 
diagnosing patients with esophageal spasm and abnormal bolus transit [24]. 
  
STANDARD MANOMETRIC PROTOCOL AND ADJUNCTIVE TESTS DURING 
MANOMETRY 
Before starting each study of esophageal manometry, the equipment should be checked and 
calibrated. Patients should fast for a minimum of six hours for solids and two hours for liquids prior 
to the procedure. Also, the use of drugs potentially influencing esophageal motility should be 
carefully evaluated and if possible discontinued since at least three days prior to testing (i.e. 
domperidon or erythromycin). Esophageal manometry should evaluate the upper and lower 
esophageal sphincter and the peristaltic contraction of esophageal body. A standardized protocol is 
internationally recognized for performing esophageal manometry (both standard and high 
resolution), as illustrated in Table 1.  
Further, several authors have suggested that increasing esophageal workload (i.e. applying a 
‘physiologic challenge’) in manometry protocols would increase the sensitivity of the investigation 
[25]. The use of multiple rapid swallows (MRS) represents the simplest provocative maneuver. Two 
different MRS tests have been proposed, a low volume one, consisting in the administration of five 
swallows (2 ml of water per swallow) in rapid sequence (less than 10 sec) and a high volume one 
(also named free drinking test), consisting in free rapid drinking of 200 ml of water. Indeed, when 
multiple swallows are rapidly administered, esophageal peristalsis is deeply inhibited, and 
pronounced LES relaxation ensues. After the last swallow of the series, a robust esophageal 
contraction is expected [26], the so-called “peristaltic reserve”. Abnormal responses consist of 
incomplete inhibition (when contraction fragments are seen during the period of expected 
inhibition), or suboptimal contraction (when the post-MRS sequence fails to demonstrate 
augmentation of smooth muscle contraction) [26, 27]. Use of both low and high volume MRS in the 
same patient has shown that the former evaluates the peristaltic reserve, the latter is more valuable 
in identifying increased resistance to outflow, whereas both evaluate motor inhibition [28] The 
International High Resolution Manometry Working Group has acknowledged usefulness of low 
volume MRS in assessing peristaltic reserve in ineffective esophageal motility (IEM) [29]. 
Recently, Martinucci and co-workers showed an inverse correlation between low volume MRS 
response and acid exposure time in patients with negative endoscopy heartburn [30]. 
Other authors have proposed challenging esophageal function by introducing viscous 
solutions (e.g., apple sauce), solid bolus (e.g., marshmallow, cubed bread), or a test meal into the 
protocol [31-33]. For instance, Wang et al. [34] evaluated and standardized a high volume water 
test, multiple water swallow (MWS), performed with 200 mL of water and a solid test meal, which 
seemed to increase the diagnostic yield of HRM studies in patients with symptoms after 
fundoplication and to identify additional patients with outlet obstruction who may benefit from 
endoscopic dilatation. However, these tests need to be better standardized, because they seem to be 
more useful for provoking symptom events than detecting abnormal esophageal motor patterns.  
To summarize, for the time being we suggest to incorporate both low volume and high 
volume MRS in all standard manometric studies unless a major motility disorder has been 
diagnosed using single water swallows 
 
CLASSIFICATION OF ESOPHAGEAL MOTILITY DISODERS 
Standard manometry. The first classification of esophageal motility abnormalities was suggested 
by Spechler and Castell in 2001 [35] and was based on abnormalities of the LES (both resting 
pressure and relaxation) and esophageal peristalsis, as shown in Table 2. The processes that affect 
the inhibitory innervation of the LES can cause inadequate sphincter relaxation. The abnormalities 
of esophageal wave propagation affecting the body of the esophagus were classified as 
uncoordinated contraction, hypercontraction and hypocontraction [35]. The basal LES pressure is 
considered normal in the range between 10-45 mmHg. The LES relaxation is considered normal 
when the LES residual pressure is lower than 8 mmHg. The distal wave amplitude is considered 
normal when the average value of 10 swallows (at two recording sites positioned 3 and 8 cm above 
the LES) ranges between 30 and 180 mmHg. In case of wave amplitude < 30 mmHg we have an 
ineffective peristalsis, whereas in case of wave amplitude >180 mmHg we have a nutcracker 
esophagus. Further, in case of simultaneous contraction in more than 1 swallow we have a diffuse 
esophageal spasm. This classification is simple; however, even for experienced physiologists in 
tertiary centers, inter-observer agreement in the interpretation of manometric measurements is poor 
[36]. 
HRM and the Chicago Classification. The enhanced pressure resolution and the objective 
metrics of esophageal function are immediately available with HRM/EPT and can be applied to 
classify individual swallows and generate an esophageal motility diagnosis.  
Esophagogastric junction (EGJ). Two different constituents compose the EGJ: the lower 
esophageal sphincter (LES) and the crural diaphragm (CD) [37]. The EGJ morphology is simply 
classified into three types: type I, there is a complete overlap of CD and LES with no spatial 
separation evident on the Clouse plot; type II, LES and CD are partially separated (double-peaked 
spatial pressure variation plot), but the nadir pressure between the two peaks does not decline to 
gastric pressure; type III, in which LES and CD are clearly separated as shown by a double peaked 
spatial pressure variation plot and the nadir pressure between the peaks equal to or less than gastric 
pressure [29]. Different EGJ characteristics (type, resting pressure, contractile integral) were 
recently correlated with GERD [38-40]. During swallowing, EGJ relaxation is evaluated using the 
integrated relaxation pressure (IRP). This is defined as the mean of the 4s (contiguous or non-
contiguous) of maximal deglutitive relaxation in the 10s window beginning at deglutitive UES 
relaxation. The 4-s IRP using a cutoff of 15 mmHg performs optimally with 98% sensitivity and 
96% specificity in the detection of achalasia [41]. 
EPT metrics to score individual swallows. The main HRM deglutitive peristaltic metrics 
used to evaluate esophageal contractile function are the distal contractile integral (DCI) and the 
distal latency (DL). The DCI represents the contractile vigor of the esophageal contraction. It was 
introduced with the Chicago Classification (CC) and represents the amplitude x duration x length 
(mmHg-s-cm) of the distal esophagus contraction with an isobaric contour of 20 mmHg from 
proximal to distal pressure troughs. The DL represents the interval between UES relaxation and the 
inflection point along the 30 mmHg isobaric contour where propagation velocity slows demarcating 
the tubular esophagus from the frenic ampulla (contractile deceleration point, CDP). The DL 
represents an indirect measurement of deglutitive inhibition and thus of normal peristalsis and a 
value lower than 4.5 s defines a premature contraction. The characteristics of peristaltic wave 
(contraction vigor and contraction pattern) are reported in Table 3. 
A classification scheme was initially proposed based on the analysis of clinical studies performed at 
Northwestern University and subsequently named the Chicago Classification of esophageal motility 
disorders [29]. 
Disorders with EGJ outflow obstruction. Disorders of the EGJ outflow are subdivided into 
achalasia subtypes and EGJ outflow obstruction. Three clinically relevant subtypes of achalasia 
have been defined in the CC [29, 42]: type I achalasia is characterized by 100% failed contractions 
and no esophageal pressurization; type II achalasia is defined as 100% failed contraction and 
panesophageal pressurization for at least 20% of swallows; and type III achalasia is defined as the 
presence of preserved fragments of distal peristalsis or premature contractions for at least 20% of 
the swallows [29] The CC improves our ability to diagnose and treat patients with achalasia. The 
CC (v 3.0) suggests to evaluate EGJ relaxation by means of the median instead of the mean value of 
IRP assessed with 10 swallows in order to minimize the effect of occasional outliers [43]. A 
different condition characterized by an impaired EGJ relaxation is defined EGJ outflow obstruction 
(EGJ-OO). The EGJ-OO exhibits not only an IRP greater than 15 mmHg, but also a preserved 
peristalsis and elevated intra-bolus pressure above the EGJ during peristalsis [44]. 
Major motility disorders. Major motility disorders are defined as patterns of motor function 
that are not encountered in controls in the context of normal EGJ relaxation. Aperistalsis: (absent 
peristalsis) is defined by the combination of a normal IRP and 100% failed contractions (DCI <100 
mmHg-s-cm) [35]. Type I achalasia should be considered in cases of borderline IRP [44]. Distal 
esophageal spasm (DES): it should be considered when 20% or more esophageal contractions result 
to be premature with a DL value lower than 4.5s in a context of normal EGJ relaxation [45]. 
Hypercontractile disorders (Jackhammer esophagus): it is defined as the occurrence of 
>20% of swallows with a DCI >8000 mmHg-s-cm and normal latency. When the hypercontractility 
can involve the LES or even might be restricted to the LES, it is necessary to expand the DCI 
measurement to the EGJ [29, 46]. 
Minor motility disorders. The clinical significance of minor motility disorders continues to 
be debated. Ineffective esophageal motility (IEM): it is defined as ≥ 50% ineffective swallows based 
on a DCI < 450 mmHg-s-cm. No distinction needs to be made between failed swallows and weak 
swallows. Fragmented peristalsis: it is defined as ≥ 50% fragmented contractions (large breaks >5 
cm in the 20-mmHg isobaric contour) with the added stipulation of not meeting IEM criteria [29, 
47]. 
Different Equipment-based Normal Values. Currently, several different HRM systems are 
commercially available and in addition new types of catheters are being developed as the clinical 
importance of esophageal manometry grows. HRM is actually worldwide diffuse, and whereas in 
the United States and Europe an almost exclusive use of the 36-channel solid-state catheter exists, 
in emerging economies and the Asian Pacific region the majority of systems are water perfused. 
Normative thresholds have been collected in different studies by means of the available 
HRM systems. These different thresholds seem to be influenced by demographic factors, catheter 
diameter, body position during testing, consistency of bolus swallows, and esophageal length. Thus 
it would be ideal to have different sets of normal values for each of these factors, yet at the moment 
the amount of normative data is limited. In Table 4 the most important studies and the different 
thresholds for each HRM system are reported [31, 48-57]. 
Finally, a recent European multicenter study reported the normal values of esophageal 
motility after anti-reflux surgery in patients who did not develop dysphagia [58]. HRM metrics after 
Toupet fundoplication were found similar to normal values derived from healthy subjects used for 
CC. However, after Nissen fundoplication a higher EGJ resting pressure and higher IRP were 
observed in asymptomatic subjects suggesting that this could be considered normal in the 
postoperative setting [58]. The results from this study are reported in Table 5. 
Clinical Indications for Esophageal Manometry 
Manometry is an excellent tool to define the integrity of peristalsis and EGJ function. In 
fact, it permits to detect functional abnormalities potentially related to esophageal symptoms: absent 
or weak peristalsis, hypercontractile peristalsis, abnormalities of EGJ pressure (i.e. defective or 
hypercontractile LES), and impaired EGJ relaxation (i.e. achalasia, outflow obstruction). However, 
it must be stressed that, at present, the relationship between these abnormalities and esophageal 
symptoms is unclear, so that it will remain the object of research in the next years, particularly with 
the wide application of HRM with or without impedance. In Table 6, the recommendations for the 
clinical indications for the use of esophageal manometry have been summarized. 
 
GASTRO-ESOPHAGEAL REFLUX DISEASE AND RUMINATION 
SYNDROME 
Diagnosis of GERD. GERD is a condition which develops when the reflux of stomach 
contents causes troublesome symptoms and/or complications [59]. Esophageal manometry is of 
limited value in the primary diagnosis of GERD. Several investigations carried out with 
conventional manometry have demonstrated that a decreased basal LES pressure, low contraction 
wave amplitude and a hiatal hernia were more prevalent in patients with GERD than in controls [60, 
61]. Further, these findings well correlated with the increasing severity of esophageal mucosal 
injuries, being high-grade esophagitis or long-segment Barrett’s esophagus the conditions with the 
lowest values of both basal LES pressure and wave amplitude and the highest frequency of HH [62-
66]. However, these features had shown limited sensitivity and specificity [67] Similar findings 
were observed with HRM, which offers the advantage of clearly defining the two components of the 
EGJ, the LES and the CD, and better characterizing the esophageal body peristalsis [38, 39, 68, 69]. 
Decreased values of EGJ pressure, increased frequency of HH (clear separation between LES and 
CD) and higher prevalence of peristalsis breaks were more common in patients with GERD 
compared to healthy volunteers and subjects with functional heartburn [23, 40, 60, 70-73], but again 
the predictive value of these findings is low, and therefore manometry, either conventional or HRM, 
cannot be used to make a diagnosis of GERD [47, 67]. The reason for this limited diagnostic value 
is likely due to the presence of other potential mechanisms involved in GERD pathophysiology, 
including hypersensitivity of esophageal mucosa and TLESRs [74-78]. With regard to TLESRs, 
HRM has shown an increased capability in detecting them, but confirmed that it is not the absolute 
number of TLESRs but, rather, the proportion of TLESRs associated with both acid and non-acid 
reflux that differentiates patients with GERD from controls, further highlighting the limited 
diagnostic value of manometric features for GERD [74, 79, 80].  
Manometry should be used to aid the placement of transnasal pH or pH-impedance probes 
for reflux testing. Conventionally, catheters for performing reflux monitoring should be positioned 
5 cm above the proximal margin of the LES. Different methodologies have been proposed, 
including pH electrode withdrawal (detection of pH increase as a measure of passage from the 
stomach to the esophagus), endoscopy, fluoroscopy, calculation according to subject height, or 
manometry. Of these methods, the manometric definition of LES borders remains the most accurate 
one [81, 82], except in the very young pediatric population, in which antropometric measure well 
correlated with esophageal length [83]. 
Anti-Reflux Surgery. Manometry is recommended before antireflux surgery in patients 
with typical GERD symptoms, primarily to rule out achalasia, severe hypomotility (scleroderma-
like esophagus), non-reflux induced esophageal spasm or hypercontractile esophagus, conditions 
that would be contraindications to surgical fundoplication, but not to tailor the operation [84-87]. 
Indeed, some experts consider impaired peristalsis as a relative contraindication for anti-reflux 
surgery or for considering Toupet 270° instead of Nissen 360° fundoplication, because the former 
one has been associated with a lower risk of dysphagia after surgery [88]. However, to date, definite 
data on this controversial issue have not been published [67]. Ongoing research with the more 
sensitive techniques to assess bolus flow (impedance associated with either conventional or HRM) 
and mechanical/functional defects (HRM) suggests that equally important considerations should be 
reserved to EGJ function, in terms of basal pressure and relaxation, and esophageal peristalsis [23]. 
Recently, the technique of using low volume MRS has been suggested as a useful and 
simple test to assess the presence of an adequate peristaltic reserve of the esophageal smooth 
muscle and therefore to predict dysphagia after surgery. In particular, Shaker et al. [89] showed that 
the strength of smooth muscle contraction augments almost twofold with MRS in normal controls 
and that lack of strong contraction is significantly more prevalent in GERD patients, who develop 
postoperative dysphagia [27]. This is a promising test for the surgeon in order to tailor his 
fundoplication in patients at risk for developing dysphagia. It has also been suggested that a free 
drinking test and especially a solid test meal in patients with post-fundoplication dysphagia help to 
identify symptomatic outlet obstruction in order to offer endoscopic dilatation to these patients [34]. 
However, further controlled data are needed before inclusion of these tests in clinical practice is 
recommended. On the other hand, there is no controversy on the fact that postoperative manometry 
combined with upper endoscopy or barium esophagogram is of value for the assessment of 
postoperative dysphagia, particularly when it persists for 4 weeks after surgery [67]. Indeed, they 
may reveal a migration or disruption of the wrap or abnormalities in terms of peristaltic function, 
LES pressure, and LES relaxation (i.e. wrap too tight). 
Hiatal Hernia and Rumination Syndrome. Recent published data underlined the role of 
manometry, and in particular HRM, in the identification and sizing of HH and combined 
manometry-impedance for the diagnosis of Rumination Syndrome (RS) in patients with typical 
GERD symptoms who do not respond to PPI therapy. Thanks to the ability of HRM to assess LES 
and crural diaphragm position, it has been shown that a better definition of HH can be formulated, 
in comparison with endoscopy and barium esophagogram [38-40, 90]. Whether this improved HH 
detection will be useful for the clinical and surgical management of GERD patients will be 
evaluated in future studies, but certainly we have now a more efficient and sensitive method to 
define HH and to understand its role in GERD.  
Rumination is a phenomenon characterized by retrograde flow of gastric contents into the 
mouth, otherwise known as regurgitation, due to an intragastric pressure increase [91]. Repetitive 
excessive occurrence of rumination is considered abnormal and is known as rumination syndrome. 
It occurs through 3 distinct mechanisms, thus classifying the syndrome into primary, secondary, and 
supragastric belch-associated rumination [91]. As symptoms of postprandial regurgitation are often 
mistaken for GERD or vomiting, the rumination syndrome is an underappreciated condition. 
Combined manometry-impedance can distinguish rumination from GERD. Moreover, treatment of 
the rumination syndrome consists of a thorough explanation of the mechanisms underlying the 
rumination episodes and behavioral therapy. Therefore, its clear identification and graphical 
representation is fundamental for its management. 
  
DYSPHAGIA 
Dysphagia is defined as a sensation of difficult bolus transit, and could be further subdivided 
into oropharyngeal dysphagia (difficulty in initiating a swallow) and esophageal dysphagia 
(sensation of bolus impaction along the esophagus). In case of dysphagia, an accurate medical 
history as well as the use of esophageal function testing are crucial. In the assessment of a patient 
with dysphagia, the priority is to exclude obstructive, organic causes, such as peptic or caustic 
strictures, infectious diseases and neoplastic lesions. To this purpose, the first step is usually upper 
endoscopy or barium esophagogram [67]. Furthermore, during upper endoscopy, esophageal 
biopsies should be performed in order to exclude eosinophilic esophagitis (EoE) [92]. A recent 
report described the occurrence of EoE in a patient with an achalasia pattern at manometry who 
well responded to steroids treatment both in terms of EoE and achalasia outcome [93]. [93]. Once 
organic causes of dysphagia have been excluded, esophageal manometry is the subsequent step to 
assess motility disorders that can be present in patients with dysphagia, although the relationship 
between these motor disorders and esophageal symptoms is in some cases not completely 
elucidated (i.e. DES and EGJ-OO) [94]. 
Achalasia. Of the esophageal motility disorders, achalasia is actually the most well-
established disorder, causing dysphagia due to the poor or absent bolus transit at EGJ level as 
shown by fluoroscopy or scintigraphy. Pathologically, achalasia is attributable to destruction of the 
inhibitory ganglionic neurons in the smooth muscle esophagus and this leads to incomplete or 
absent LES relaxation and aperistalsis [42]. Indeed, according to conventional manometry, 
achalasia is based on the presence of incomplete relaxation of the LES (defined as a mean resting 
LES pressure > 8 mmHg above gastric pressure) and aperistalsis of the esophageal body (presence 
of simultaneous esophageal contractions or no esophageal contractions [35]. HRM allowed to 
refining the definition of both these criteria, greatly improving the accuracy in its diagnosis and 
inter-observer reproducibility [29, 42, 95] HRM is able to precisely evaluate LES residual pressure, 
CD contraction, or intrabolus pressure through the EGJ. The HRM parameter that encompasses 
these features is IRP, which is measured within the deglutitive window of the LES, starting from 
the initiation of the swallow until the arrival of the peristaltic contraction, and represents the 4s 
period of lowest EGJ pressure during this time-window [41]. In addition to the presence of impaired 
LES relaxation, HRM allowed to identify three subtypes of achalasia [29]. Consequently, achalasia 
has been defined in presence of elevated median IRP (>15 mmHg) with 100% failed peristalsis 
(Type I, classic achalasia) or with 100% failed peristalsis and panesophageal pressurization with 
≥20% of swallows (Type II, achalasia with esophageal compression) or with no normal peristalsis, 
premature contractions with ≥20% of swallows (Type III, spastic achalasia) [29]. An important 
consideration is that the cutoff for the upper limit of normal is technology-specific, ranging from a 
low value of 15 mmHg for the Sierra design transducers to as high as 28 mmHg for the Unisensor 
design [20]. A second caveat is that achalasia may be present also in case of an IRP or LES residual 
pressure within the normal values [43], emphasizing that the diagnosis of achalasia always requires 
a detailed anamnesis and a multi-diagnostic meaningful approach, including manometry, upper 
endoscopy and radiology. As to the clinical usefulness of identifying different manometric 
subtypes, it has been demonstrated that type II achalasia were significantly more likely to respond 
to any therapy, followed by type I and type III [95]. Recently, it has been reported that a higher 
percentage of patients with type II achalasia are treated successfully with pneumatic dilation or 
laparoscopic Heller myotomy than patients with types I and III achalasia. Success rates in type II 
are high for both treatments, but significantly higher in the pneumatic dilation group, whilst patients 
with type III can probably be best treated by laparoscopic Heller myotomy or peroral endoscopic 
myotomy (POEM) [96]. Recently, short-term outcome data after POEM have been published [97]. 
POEM is a recently developed achalasia treatment method, which combines the efficacy of surgical 
myotomy with the benefits of endoscopic procedures [98]. The first report of over 100 cases of 
patients with achalasia treated with POEM were extremely good and independent of age, type 
of achalasia, and previous treatment method [97]. Further, data from prospective single or 
multicenter studies have been published confirming the potential positive outcome of this 
endoscopic approach in all types of manometry-detected achalasia [99, 100]. However, randomized 
clinical trials are mandatory before suggesting this approach outside the research setting. Finally, 
pseudoachalasia accounting for up to 5% of cases, should be always considered, particularly in 
patients older than 50 years [101]. 
EGJ outflow obstruction. EGJ-OO encompasses the group of dysphagia patients with 
impaired EGJ relaxation, but not meeting the criteria for achalasia because they demonstrate intact 
peristalsis [29]. Besides IRP value > 15mmHg and intact peristalsis, patients with EGJ outflow 
obstruction have often increased intra-bolus pressure above the EGJ, being the consequence of the 
impaired relaxation. The outflow obstruction could be sustained by a premature or incomplete 
expression of achalasia or by undetected mechanical causes, such as hiatus hernia or organic 
stenosis. Consequently, these patients should be handled carefully with further imaging studies, in 
order to exclude inflammatory or malignant etiologies. Once EGJ-OO has been confirmed, patients 
might reasonably benefit from the same approach of achalasia patients, but limited outcome data are 
available [102]. 
Distal esophageal spasm. DES represents a motility disorder often associated with 
dysphagia, whose diagnostic criteria have been changed from conventional manometry to HRM era. 
According to CC, DES is defined by normal median IRP with ≥ 20% premature contractions (distal 
latency < 4.5 seconds) [29]. The presence of relaxed LES is crucial to distinguish DES from type III 
achalasia. In case of dysphagia with manometric evidence of DES, treatment is recommended. 
Nitrates and calcium channel antagonists could be useful [103]. Sildenafil seems to be effective, as 
confirmed by improved manometric findings. Endoscopic treatment, like botulin injection or 
POEM, need to be further evaluated, given the paucity of available data [104, 105]. 
Hypercontractile esophagus. According to conventional manometry, the presence of 
nutcracker esophagus was defined by the presence of distal esophageal wave amplitude > 
180mmHg with preserved LES function [35]. However, the clinical relevance of nutcracker 
esophagus has been challenged, since its presence may or may not be associated with dysphagia. It 
has been reported that up to 97% of patients with nutcracker esophagus have normal bolus transit, 
assessed by multichannel impedance [106]. As to HRM, the latest version of CC has identified the 
hypercontractile esophagus (jackhammer) by the presence of at least two swallows with DCI > 
8000 mmHg/s/cm with normal LES relaxation. The cut-off of 8000 mmHg/s/cm is a value never 
observed in normal subjects and is highly associated with dysphagia. The clinical value of this 
modified manometric entity has to be fully elucidated as well as its management, although 
preliminary data on the use of botulin toxin injection during upper endoscopy in patients with 
hypercontractile esophagus and dysphagia seem to corroborate the relationship between this 
manometric abnormality and esophageal symptoms, and thus to suggest its treatment [104]. If 
patients with hypercontractile esophagus or DES have predominant chest pain, an empirical PPI 
trial should be done, because GERD may be associated and responsible for chest pain 
independently of motor abnormalities and no convincing effects of PPIs on esophageal motility 
have been shown [107, 108]. 
Hypomotility disorders. The definition of IEM has been used with conventional 
manometry to describe an esophageal motility pattern similar to that observed in scleroderma 
patients, and characterized by at least 30% of swallows with distal esophageal peristaltic amplitude 
< 30mmHg or failed/absent peristalsis. This definition, however, encompasses a large group of 
individuals with or without dysphagia [35]. HRM allows us to better assess the peristaltic vigor and 
integrity, leading to (perhaps) a better comprehension of esophageal hypomotility and its 
relationship with esophageal symptoms. Based on HRM studies, IEM is defined by ≥ 50% 
ineffective swallows (failed or weak swallows, i.e. DCI < 450 mmHg/s/cm), whereas fragmented 
peristalsis is defined by presence of ≥ 50% fragmented contractions [29]. The main dilemma of 
esophageal hypomotility is that not all patients with weak peristalsis display incomplete bolus 
transit and/or dysphagia. Furthermore, a major limitation in identifying this kind of minor motility 
abnormalities is the lack of an effective medical treatment to adopt. Indeed, treatment options as 
prokinetics, erythromycin or metoclopramide have been used, but their benefit is not definitely 
established. A possible reason for the lack of effect of prokinetics is that esophageal peristalsis does 
not improve in part of the patients after their administration. Selection of patients with a peristaltic 
reserve using low volume MRS may improve outcome of prokinetic treatment, but this hypothesis 
needs to be tested. The future concomitant evaluation of motor activity (i.e. pressure) and bolus 
transit (i.e. impedance) with the use of HRM combined with impedance will be likely of help to 
clarify the relationship between hypomotility, bolus transit and dysphagia. 
Gastro-Esophageal Esophago-gastric Surgery. Manometry should be used to evaluate 
patients with a suboptimal response to achalasia treatment, either surgical or endoscopic, and should 
be always performed in association with a timed barium swallow to demonstrate poor esophageal 
emptying [42]. Indeed, surgical or pneumatic dilation or POEM failure may be due to an incomplete 
myotomy or inadequate disruption of the LES, scarring, functional obstruction by Dor 
fundoplication in case of surgery, para-esophageal hernia, or profound esophageal dilatation [109, 
110]. Recent data also emphasize the need for a more complete diagnostic approach in patients who 
undergo bariatric surgery with restrictive operations, like gastric or mini-gastric bypass, because of 
the potential development of esophageal symptoms due to under-recognized or silent motility 
abnormalities [111-113]. 
  
NON CARDIAC CHEST-PAIN  
 
Non cardiac chest pain (NCCP) is a troublesome condition of difficult diagnosis, with 
potentially underlying musculoskeletal, neuropathic, pulmonary, vascular and esophageal causes 
[114]. Chest pain of esophageal origin may be caused by GERD, motor abnormalities like achalasia 
or DES, or altered sensitivity. Among them, GERD is by far considered the most common cause of 
chest pain and chest pain is commonly reported among patients with typical reflux symptoms (37%) 
[115], NCCP patients frequently complain of heartburn and regurgitation (53-58%) [116] and a 
large proportion of them respond to PPI test [117, 118]. Thus, the role of esophageal manometry in 
the evaluation of NCCP is particularly challenging and has been matter of debate in the last 20 
years. 
Studies with conventional manometry have shown esophageal motor abnormalities in 30-
70% of cases, probably depending on patient selection and hospital interest. In a center dedicated to 
motility disorders only 30% of patients showed motor disorders, the most common finding being 
nutcracker esophagus, observed in 14.4%, and non-specific esophageal disorders were described in 
10.8% [119]. In a non-dedicated hospital the most common finding was hypotensive lower 
sphincter, probably reflecting the inclusion of GERD as a cause of chest pain [120]. Achalasia, 
DES, hypertensive LES were uncommon findings and this leaded to underscore the role of 
manometry in the diagnostic algorithm of NCCP.  
Presence of heartburn/regurgitation or dysphagia may guide the physician toward the 
suspicion of GERD or major motility disorders, such ad achalasia or hypercontractile conditions. In 
contrast, when chest pain is an isolated symptom with episodic appearance, the causal relationship 
between symptom and manometric findings is difficult to demonstrate. Furthermore, the non-
specific and often heterogeneous motor alterations found in patients with chest pain may only 
represent an epiphenomenon rather than the underlying mechanisms. The prolonged measurement 
with 24-h esophageal manometry did not significantly improve the sensitivity in NCCP, being the 
correlation between symptom and motor abnormalities found only in 23-24% of patients [121].  
The introduction of HRM with a topographic assessment of esophageal pressure leading to 
development of new parameters and the new classification of motor disorders with definition of 
specific entities - such as distal esophageal spasm and jackhammer esophagus [29] - may also allow 
to better investigate segmental abnormalities potentially related to acid exposure [122]. 
Furthermore, provocative tests, such as balloon distension, may still help in defining a condition of 
hypersensitivity in patients with functional chest pain [123]. 
In conclusion, in the absence of symptoms suggesting major motor disorders, the diagnostic 
yield of esophageal manometry is limited in NCCP. HRM defines new pathological entities, 
however data on the prevalence of these new entities in the NCCP population are still incomplete. 
Thus, HRM should ideally be performed in all patients with NCCP pain within large multicentric 
studies with uniform instruments and reference parameters.  
However, keeping an eye on cost-effectiveness, data borrowed from conventional 
manometry in clinical practice suggest the following indications: a) if chest pain is suspected to be 
due to GERD and prolonged pH-monitoring is indicated, manometry is mandatory for establishing 
placement of intraluminal device; b) if  chest pain is accompanied by dysphagia, manometry is 
strongly indicated after organic obstructions are ruled out; c) if chest pain is an isolated symptom, a 
trial with PPI can be performed prior to manometric study; d) manometry can be considered as first 
line procedure in the setting of large clinical and research studies. 
  
SYSTEMIC DISEASES 
Several systemic conditions affecting neuromuscular function are associated with altered 
gastro-intestinal motility, such as scleroderma and collagen diseases, diabetes, generalized motility 
disorders. One of the most characteristic manometric alterations is found in scleroderma patients 
with esophageal involvement [124, 125]. In these patients, reduced LES pressure with a severely 
impaired or absent contractile activity in the 2 distal thirds of the esophagus and preserved motility 
of the upper esophagus is typically found [126, 127]. Clinically, this often results in dysphagia and 
GERD along with its complications. More recent studies have demonstrated that patients with SSc 
and interstitial lung disease have reduced LES pressure and distal esophageal peristaltic activity and 
these manometric features have been associated with more severe reflux disease, potentially 
contributing to the pulmonary condition [128]. In localized scleroderma (i.e. systemic sclerosis and 
morphea), despite the presence of symptoms, conventional manometry did not show esophageal 
motility alterations in adults [129], while in a pediatric population of juvenile localized 
scleroderma, non-specific esophageal motor abnormalities were found in 1/3 of patients with 
antinuclear antibodies (ANA) positivity, even in absence of specific symptoms [130]. Esophageal 
motor alterations in SSc have been recently further characterized using HRM, confirming high 
prevalence of esophageal body dysmotility (67.3%), hypotensive EGJ in 55.1% of patients, with 
reduced amplitude contractions in middle esophagus; esophageal involvement was associated with 
Scl70 and absence of anticentromere anitbodies (ACA), esophageal symptoms were highly 
prevalent (87.5%), but not predictive of esophageal dismotility [131]. 
In Sjogren syndrome, dysphagia has been attributed not only to reduced salivary flow, but 
also to possible presence of dismotility: studies with conventional manometry have shown the 
presence of non-specific peristaltic alterations, reduced velocity as well as altered LES pressure. 
Furthermore, association with nutcracker esophagus and achalasia has also been reported [132]. 
Altered gastro-intestinal motility in diabetes is well known, involving particularly gastric 
motility with delayed emptying, especially in long lasting disease and in presence of complications. 
In these patients esophageal motor alterations have also been observed, and recent studies using 
HRM have found impaired contractile inhibition during multiple swallowing and increased intra-
bolus pressure, as possible consequence of gastroparesis or expression of neuropathy [133]. 
However, the above-mentioned motility abnormalities are neither sensitive nor specific for 
collagen vascular diseases and can be found in GERD patients without them. For this reason, a 
previous American Gastroenterological Association position statement omitted specific guidelines 
for the study of patients with collagen disease, limiting the use of esophageal manometry in 
symptomatic patients [134]. 
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